Physiomics (LON:PYC) Shares Up 32.5% – What’s Next?

Shares of Physiomics Plc (LON:PYC) rose 32.5% on Thursday . The stock traded as high as GBX 0.55 and last traded at GBX 0.53. Approximately 53,932,113 shares traded hands during trading, an increase of 535% from the average daily volume of 8,498,946 shares. The stock had previously closed at GBX 0.40.

Physiomics Trading Up 0.6%

The stock’s 50-day moving average price is GBX 0.41 and its 200-day moving average price is GBX 0.40. The company has a market capitalization of £1.53 million, a P/E ratio of -3.35 and a beta of 1.01.

Physiomics (LON:PYC) last announced its quarterly earnings data on Monday, February 16th. The company reported GBX (0.10) earnings per share for the quarter. Physiomics had a negative net margin of 50.92% and a negative return on equity of 89.43%. Sell-side analysts expect that Physiomics Plc will post -0.13 earnings per share for the current fiscal year.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.